Conditions and claims · Reviewed October 30, 2026
Epilepsy in dogs and pet insurance: the first seizure date, the medication clause and the lifetime limit
The date of the first recorded seizure decides most epilepsy claims, and the condition is common enough to plan for: veterinary consensus estimates it at 0.6 to 0.75 percent of dogs. If that first episode falls after the policy starts and its waiting period ends, pet insurance usually covers the emergency visit, the MRI workup and years of medication. If it falls before, the insurers read for this guide treat seizure disorders as chronic and never cured, so the condition is normally excluded for life.
That date is written down by whoever sees the episode first: the emergency clinic, the family veterinarian, sometimes the owner in a phone call to the practice. After that, three pieces of policy wording decide what the claim is worth over a dog's life. They are how the form defines a chronic condition, whether its medication benefit is tied to drugs "approved by the FDA", and whether its limit resets every year or follows one condition for good.
This guide reads those clauses against published veterinary consensus and real policy documents, then runs five years of an illustrative epilepsy claim through three policy shapes. Calling an episode a seizure, finding its cause and choosing a treatment are a veterinarian's job, not this page's; the policy documents are compared as insurance education, and none is ranked above another. Every dollar figure is either quoted from a named source with a check date or labelled as an illustration with its inputs stated.
What counts as a seizure, a cluster and epilepsy, in the vocabulary a claims file uses
The International Veterinary Epilepsy Task Force (IVETF), a group of veterinary neurologists, published a consensus classification in BMC Veterinary Research in 2015 that most specialist records now follow. It defines epilepsy as a disease of the brain with an enduring predisposition to generate epileptic seizures, applied in practice as "at least two unprovoked epileptic seizures >24 h apart." It separates that from a reactive seizure, which it describes as a natural response of a normal brain to a transient metabolic or toxic disturbance, reversible when the cause is corrected.
Within epilepsy, the task force sorts causes into two broad groups. Structural epilepsy is provoked by pathology inside the skull, such as inflammatory, traumatic, developmental, neoplastic or degenerative disease, confirmed by imaging, spinal fluid testing or other tests. Idiopathic epilepsy has "no underlying cause other than a possible hereditary predisposition." Two more terms matter for the bill. Cluster seizures are defined clinically as two or more seizures within a 24 hour period. Status epilepticus is more than 5 minutes of continuous seizure activity, or two or more seizures without full recovery of consciousness in between. Both are emergencies, and both tend to arrive at an emergency hospital rather than a scheduled appointment.
Why spell this out in an insurance guide? Because each word can end up in the record that a reviewer reads. A single episode written up as a "seizure-like event" before enrollment, a reactive seizure after a dog ate something toxic, and a first idiopathic seizure are three different facts, and the policy reads them through its own definitions. The Spot Arizona sample policy (form PET-P-20000-1024), read for this guide on October 30, 2026, says a condition occurs when signs "first were observed by any individual, recorded in your pet's medical record, or would have been detectable by a routine physical veterinary exam." A seizure is rarely detectable at a routine exam, but it is very often observed and recorded, so the first record usually fixes the date.
The seizure workup, read as an invoice
The IVETF diagnostic consensus, also published in 2015, describes confidence tiers for diagnosing idiopathic epilepsy, and those tiers map neatly onto the lines of a bill. Tier I rests on two or more unprovoked seizures at least 24 hours apart, onset between 6 months and 6 years of age, a normal examination between seizures, and no significant abnormalities on blood tests and urinalysis. Tier II adds normal bile acid tests, an MRI of the brain using an epilepsy protocol, and cerebrospinal fluid analysis. The task force recommends MRI and spinal fluid testing for dogs whose seizures start before 6 months or after 6 years, dogs with neurological abnormalities between seizures, and dogs presenting with status epilepticus or cluster seizures, among others.
Very few clinics publish prices for these steps. The University of Missouri Veterinary Health Center is one that does: its neurology FAQ lists the initial neurologic exam and evaluation at $195 and says that if higher level imaging is recommended, MRI or CT "would be between $3,000-$4,000", a figure that includes the imaging, the anesthesia, pre-anesthetic blood work and radiographs the doctor considers necessary, and a spinal fluid tap and testing. The page notes that prices are evaluated annually and subject to change. The MRI and CT scan cost guide explains what that package does and does not include.
| Stage | What the published source describes | Published price | Policy question to ask |
|---|---|---|---|
| Emergency visit for a cluster or status epilepticus | IVETF: two or more seizures in 24 hours, or more than 5 minutes of continuous seizure activity | None published by a primary source; varies by hospital | Is the visit inside the illness waiting period? Is the emergency exam fee covered or excluded? |
| First-opinion blood tests and urinalysis | IVETF Tier I: minimum data base blood tests and urinalysis with no significant abnormalities | Clinic-specific | Are diagnostics paid when the result is normal? (Most forms pay diagnostics for a covered illness.) |
| Neurologist consultation | Referral exam and evaluation | $195, University of Missouri VHC | Are specialist exam fees covered? Some forms exclude exam fees unless an add-on is bought |
| MRI with spinal fluid analysis | IVETF Tier II: epilepsy-protocol brain MRI and CSF analysis | $3,000 to $4,000 including anesthesia, pre-anesthetic tests and CSF tap, University of Missouri VHC | Is there a diagnostic sub-limit? Does the anesthesia count inside the imaging benefit? |
| Daily anti-seizure medication | IVETF treatment consensus: treatment for idiopathic epilepsy "generally" involves lifelong drug administration | Pharmacy-specific | Does the medication benefit require FDA approval, and how does it treat conditionally approved or human-market drugs? |
| Drug-level and blood monitoring | IVETF: for phenobarbital, blood count and biochemistry before treatment, at 3 months and every 6 months; serum drug levels every 6 months when control is adequate | Clinic-specific | Are recheck exams covered, and does the annual deductible apply again each year? |
Clinical stages summarised from the IVETF consensus papers for insurance education only; they describe what a record may contain, not what any dog needs. The Missouri figures are one teaching hospital's published estimate, not a national price.
Two features of this invoice are unusual. The expensive part, imaging, may come in the first year and then not again, while the cheap part, medication and monitoring, continues indefinitely. And the first line is often an emergency, which is where an exam-fee exclusion bites hardest. The exam fees guide compares how forms treat that line, and the emergency vet visit guide breaks down what an emergency invoice usually contains.
The medication clause that can matter more than the MRI
Here is a detail that rarely appears in coverage articles. Some policy documents tie their medication benefit to approval by the US Food and Drug Administration. The Spot Arizona sample lists, among eligible expenses, "Prescription medications prescribed by a veterinarian and approved by the Food and Drug Administration (FDA)." Embrace's prescription coverage page, read October 30, 2026, says its take-home medication cover is available with every policy and applies to "FDA-approved and Homeopathic Pharmacopoeia-included drugs prescribed for covered conditions."
The FDA's own pages trace how the oldest seizure drugs moved toward approval for dogs. Its 2021 explainer on potassium bromide, current as of February 12, 2021, said at that time: "Despite both drugs' long history of common use, neither is fully approved by FDA to control seizures in people or animals", referring to phenobarbital and potassium bromide. That statement is now history for one of the two. In January 2021 the agency conditionally approved KBroVet-CA1, a potassium bromide product for dogs with idiopathic epilepsy, and on January 21, 2026 it announced that it "has granted full approval to KBroVet (potassium bromide chewable tablets) for the control of seizures in dogs with idiopathic epilepsy", after four annual renewals of the conditional approval. Phenobarbital is a step behind. On September 6, 2023 the FDA conditionally approved Fidoquel-CA1, a phenobarbital tablet, which it called "the second drug to receive FDA approval for the control of seizures in dogs with idiopathic epilepsy", and noted that "Unapproved phenobarbital tablets from the human drug marketplace have historically been used in veterinary medicine." A conditional approval, the FDA explains, is valid for one year with up to four annual renewals, and the sponsor has five years to reach full approval or the drug can no longer be marketed. No full-approval notice for Fidoquel-CA1 was found in the FDA pages read on October 30, 2026, so on that record it remains conditionally approved.
The IVETF treatment consensus adds that several newer drugs approved for people are also used to manage canine idiopathic epilepsy, mainly as add-on treatment. So an epileptic dog's prescription list can contain a fully approved veterinary product (KBroVet), a conditionally approved one (Fidoquel-CA1), a human-market tablet that was never approved for this use, or a human drug used outside its label. Cat owners meet the same FDA-approved clause in its starkest form with FIP, where the main antiviral is compounded from bulk and has no approval at all, as the guide to FIP treatment cover sets out. None of the documents read for this guide says how it would treat each of those, and this guide does not suggest any insurer refuses them. It is a question worth asking in writing before a diagnosis, because medication is the one line of an epilepsy claim that repeats every month for life.
| Document | Medication wording | What to ask for a seizure prescription |
|---|---|---|
| Spot Arizona sample policy (PET-P-20000-1024) | Prescription medications prescribed by a veterinarian and approved by the FDA | Does "approved" include conditional approval, and approval for people rather than dogs? |
| Embrace prescription coverage page | FDA-approved and Homeopathic Pharmacopoeia-included drugs prescribed for covered conditions; no prescriptions for pre-existing conditions | Is a human-market phenobarbital tablet treated as FDA-approved? Is a compounded liquid paid? |
| AKC Pet Insurance North Carolina sample (IAIC PPI AI POL 007 NC 0421) | Any medicine dispensed from a veterinarian pharmacy or with a written prescription from a veterinarian that may only be filled at a pharmacy; no FDA test in the definition | Is epilepsy treated as inherited under the congenital and inherited exclusion? (The list printed in the form does not name it.) |
Wording as printed by each insurer. Sample forms are single-state examples; your declarations page and policy form govern. FDA approval status as of the FDA pages read October 30, 2026: KBroVet (potassium bromide) fully approved January 21, 2026; Fidoquel-CA1 (phenobarbital) conditionally approved September 6, 2023, with no full-approval notice found. Check the current label status with your veterinarian.
Five years of one epileptic dog through three policy shapes (stated inputs)
Round numbers, not prices, apart from the Missouri figures. A dog enrolled as a puppy has its first cluster of seizures at age 3, two years into the policy. Year 1 of the claim brings a $1,500 emergency visit, the $195 neurologist exam, a $3,500 imaging package (the middle of Missouri's published $3,000 to $4,000 range), $500 of medication and $300 of monitoring blood work: $5,995. Each later year brings $600 of medication and $400 of monitoring, $1,000 a year, plus a second $1,500 emergency visit in year 3. Five-year total: $11,495.
Every policy has a $500 annual deductible and 80 percent reimbursement. Shape A pays everything eligible, with a $10,000 annual limit that resets each year. Shape B excludes exam fees and has a $5,000 per-incident limit that does not reset, the structure the AKC sample describes when it says a recurring or chronic incident counts as one incident and per-incident limits "will not reset at Policy renewal or replacement." Shape C is Shape A with the medication lines refused, to show what that one clause is worth if a prescription falls outside a benefit.
| Claim year | Bill | Shape A: annual limit, all lines | Shape B: no exam fee, $5,000 per incident | Shape C: Shape A without medication |
|---|---|---|---|---|
| Year 1: emergency, neurologist, imaging, start of treatment | $5,995 | (5,995 - 500) x 80% = $4,396 | (5,800 - 500) x 80% = $4,240 | (5,495 - 500) x 80% = $3,996 |
| Year 2: medication and monitoring | $1,000 | $400 | $400 (running total $4,640) | $400 of blood work is below the deductible: $0 |
| Year 3: second emergency, medication, monitoring | $2,500 | $1,600 | $360, which reaches the $5,000 incident cap | (1,900 - 500) x 80% = $1,120 |
| Year 4 | $1,000 | $400 | $0, cap reached | $0 |
| Year 5 | $1,000 | $400 | $0 | $0 |
| Five years | $11,495 | Insurer $7,196; owner $4,299 | Insurer $5,000; owner $6,495 | Insurer $5,116; owner $6,379 |
The headline figures hide the more useful lesson. All three shapes pay well in year one, when the bill is large. They separate in the quiet years, when the claim is a steady $1,000 of tablets and blood tests. A per-incident cap that does not reset runs out in year 3 and pays nothing thereafter, however long the dog lives. A medication exclusion turns each quiet year into a bill smaller than the deductible, so it pays nothing either. Only the shape with a resetting annual limit and paid medication keeps contributing. For a dog that may need daily treatment for a decade, that difference compounds. Run your own quote's numbers through the claim payout simulator using your clinic's estimate.
Illustration with stated inputs. Only the $195 exam and the $3,000 to $4,000 imaging range are published figures (University of Missouri VHC). Shapes A to C are generic structures, not any insurer's product, and the result is before any other exclusion or waiting period.
Chronic, not cured, one incident: the words that set the lifetime value
Epilepsy is where three definitions that look like boilerplate decide real money. The first is the chronic condition. The Spot sample defines it as "a condition that can be treated or managed, but not cured", and its route for a cured pre-existing condition to count as new after 180 days free of treatment and symptoms "does not apply to chronic conditions." Lemonade's pre-existing conditions explainer, last updated October 13, 2026, says chronic conditions such as endocrine diseases "cannot be cured." Healthy Paws' FAQ names seizures among conditions that need ongoing medication and are not considered cured, and separately lists epilepsy among examples of hereditary conditions, which its FAQ says are eligible when signs first appear after enrollment and any waiting period.
The second is the cured-condition window, which matters because epilepsy is not always lifelong in practice. The IVETF treatment consensus reports remission rates of 15 to 30 percent in hospital-based populations. A dog that stops having seizures and comes off medication may look cured to its owner, but a form that classes epilepsy as chronic has no path back. Embrace's coverage FAQ describes curable conditions becoming eligible after 12 months symptom free, gives diabetes and allergies as examples of incurable ones, and does not name epilepsy either way, so ask.
The third is the incident. The AKC sample defines an incident as a specifically identifiable illness or injury that may include secondary or related diagnoses, and adds: "If an Incident is recurring or chronic, it will be considered one (1) Incident." Combined with a per-incident limit that does not reset, that wording is the Shape B result in the example above. The same form carries a feature that cuts the other way: it states that pre-existing conditions are only eligible after 365 days of continuous coverage and only for treatment after that waiting period. That is unusual among the documents read for this guide, and it is the one route found here by which a dog with a recorded seizure could have that condition considered at all, subject to every other term.
Breeds where the seizure clauses do most of the work
Epilepsy is not rare in general practice, and it concentrates in some breeds. In UK primary-care records from 92 clinics in the VetCompass programme, Kearsley-Fleet and colleagues (Veterinary Record, 2013) found epilepsy of unknown origin in 0.62 percent of dogs, with males over 1.5 times as likely to be affected, the Border Terrier at 2.70 times and the German Shepherd at 1.90 times the odds of crossbreds. A later VetCompass study of 455,553 dogs (Erlen and colleagues, Journal of Veterinary Internal Medicine, 2018) put the one-year prevalence of at least one seizure at 0.82 percent, gave the Pug 3.41 times the odds of the Labrador Retriever, and found dogs aged 3 to 6 at about twice the odds of dogs under 3. The FDA's pages use a higher figure, about 5 percent of dogs, for idiopathic epilepsy; the IVETF classification paper says the true prevalence is unknown and estimated at 0.6 to 0.75 percent in the general dog population. The difference is partly what each counts, and the policy reads only your dog's record.
The breed profiles on this site carry breed-specific figures from the IVETF breed review and VetCompass; those studies are listed in the sources at the end of this guide. The table repeats them with each breed's published premium anchor.
| Breed | Recorded seizure figures (as carried on the profile or cited above) | Published monthly anchor, not a quote |
|---|---|---|
| Border Collie | German study in the IVETF review: median first seizure at 2.4 years, 18 percent by the first birthday, 94 percent with at least one cluster | $44, MoneyGeek |
| Australian Shepherd | Cohort in the IVETF review: median first seizure at 2.5 years; in 28 percent the first event was a cluster or status epilepticus | $59, AdvisorSmith |
| Vizsla | US study in the IVETF review: median onset 3 years, 79 percent focal seizures | $55, MoneyGeek |
| Beagle | VetCompass 2019: seizure disorder in 2.04 percent, median age 7.45 years among affected dogs | $72, AdvisorSmith |
| Pug | Erlen 2018: 3.41 times the seizure odds of Labradors; seizures 6.7 percent of recorded deaths in Australian VetCompass data | $55, MoneyGeek |
| German Shepherd | Kearsley-Fleet 2013: 1.90 times the odds of epilepsy of unknown origin compared with crossbreds | $80, AdvisorSmith |
| Labrador Retriever | IVETF classification paper: a breed population study found idiopathic epilepsy in 3.1 percent | $85, AdvisorSmith |
Premium anchors from AdvisorSmith or MoneyGeek as labelled on each breed page, reviewed October 4, 2026: published research averages, not quotes. Breed study figures come from different populations and methods and should not be compared row against row.
Read the onset column against the enrollment date. A Border Collie with 18 percent of cases starting by the first birthday needs cover in place, and its waiting period finished, well before then. A Beagle whose seizures, in the VetCompass sample, appeared at a median of 7.45 years is more likely to have its first episode on cover, and its owner's live question is how a per-incident limit and renewal pricing behave in the dog's later years. For the herding breeds, the frequency of a cluster or status epilepticus as the first event means the first claim may be an overnight emergency before anyone has said the word epilepsy.
A seizure already in the record: what is left to insure
If a dog has had a seizure recorded before cover starts, most forms read it as the start of a pre-existing condition. The pre-existing conditions guide compares five definitions, and the guide to buying cover after a diagnosis sets out what a new policy can still do. Three seizure-specific points sit on top of those general rules.
First, the cause written in the record matters. A reactive seizure, in the IVETF sense, is a normal brain responding to a transient toxic or metabolic disturbance. If a record shows a single seizure clearly tied to, say, a toxin, and a later episode with no such cause appears years into cover, the question of whether they are the same condition is a real one. The policy, not this guide, answers it, and the related-condition wording in the pre-existing definition is where it will be decided. The Spot sample, for example, includes conditions "related to, secondary, or resultant from" a pre-existing condition.
Second, the rest of the dog is still insurable. A seizure exclusion does not remove cover for a cruciate tear, a swallowed sock or cancer, and for a young dog those risks may still justify a policy. Third, an insurer's look-back can reach further than an owner expects. Spot's Occur definition counts signs observed by any individual, so a note in a phone log that the dog "had a fit last month" is part of the record. Insurers ask for the complete history with the first claim, and an omitted episode is usually found.
Where your dog is now, and what that points to
Five common situations. None replaces reading the policy form you are quoted.
A puppy of a breed named above, no episodes on record.
Enrollment before any episode and before the illness waiting period would overlap typical onset is the whole game. Ask how the form defines chronic conditions, whether medication requires FDA approval, and whether limits reset yearly.
An adult dog, no episodes, of a breed with later typical onset.
Cover is still available on ordinary terms. The weight shifts to the lifetime value: a resetting annual limit against a per-incident cap, and how premiums rise with age.
One episode on record, cause unclear, no diagnosis.
Expect the episode, and anything related to it, to be excluded on a new policy. Ask each insurer in writing how it would treat a later seizure, and whether any form you are offered has a waiting-period route for pre-existing conditions such as the 365 day route in the AKC sample.
Diagnosed with epilepsy and on medication.
A new policy will normally exclude epilepsy for life. Price a policy for everything else on its own merits, and fund the medication and monitoring separately. The help paying vet bills guide lists the options in order.
Insured, and the first seizure has just happened.
Ask the clinic to record what was seen, when, and what is suspected, precisely. Gather the complete history, file promptly with itemized invoices, and ask before the MRI whether a diagnostic sub-limit or an exam-fee exclusion applies.
Seizure claim mistakes that cost the most
Each of these comes straight from the wording quoted above.
- Buying after the first episode "to cover the next one". On the documents read here, the next one is the same condition.
- Comparing policies on year-one payout. The example shows the policies separating in the quiet medication years, not the MRI year.
- Assuming every prescription is paid. Where the benefit is tied to FDA approval, ask how each drug on the list is treated before the first refill.
- Ignoring a per-incident limit because the annual limit looks generous. For a chronic condition counted as one incident, the smaller number is the one that binds.
- Letting a vague note stand. A "possible seizure" or "collapse episode" in the record can later be read as the first sign; ask your veterinarian to describe what was observed.
The seizure file to keep with the policy
- The policy's effective date and the end date of the illness waiting period, written where you will see them.
- The declarations page showing deductible, reimbursement rate, annual limit and any per-incident or per-condition limit.
- The policy's definitions of chronic condition, pre-existing condition and incident, and its medication benefit wording.
- A seizure diary: date, time, duration and what was seen, which also helps your veterinarian.
- Every invoice, itemized, including emergency visits, neurology, imaging, medication and monitoring blood work.
- Written answers from the insurer to the medication and limit questions in this guide, kept with the policy.
Questions owners ask about seizures and insurance
My dog had one seizure years ago and none since. Will a new policy cover epilepsy?
Usually not. Forms that treat epilepsy as chronic give it no cured-condition route, so a recorded seizure tends to stay excluded however long ago it was. Of the documents read for this guide, the AKC sample is the exception that describes a route at all: pre-existing conditions are eligible after 365 days of continuous coverage, for treatment after that wait. Ask each insurer, in writing, how it would read your dog's record.
Is an emergency visit for a seizure an accident or an illness?
An illness on every form read for this guide. The Spot sample defines illness as any sickness, disease or medical condition not caused by an accident or injury, so the illness waiting period applies. A seizure caused by a head injury may be classed with that accident, but the record of the cause decides it.
Will insurance pay for a second opinion with a neurologist?
Most accident-and-illness forms pay specialist diagnostics for a covered illness. The exam fee itself is the line to check: the AKC sample excludes physical examination fees unless its ExamPlus option is bought, and the Healthy Paws FAQ says exam fees are not covered. The University of Missouri VHC lists its initial neurologic exam at $195.
Does it matter if my dog's seizure medication is a human drug?
It can. The Spot sample and Embrace's prescription page describe their medication benefits in terms of FDA-approved drugs, and approval status differs by drug. The FDA granted full approval to KBroVet, a potassium bromide tablet for dogs, on January 21, 2026. Fidoquel-CA1, a phenobarbital tablet, has been conditionally approved since September 6, 2023, and no full-approval notice for it was found when this guide was checked on October 30, 2026. The FDA also notes that human-market phenobarbital tablets have historically been used, and in 2021 it said neither drug was then fully approved. How a policy treats a conditionally approved or human-market drug is not stated in those documents, so ask before the first refill.
If my dog goes into remission and stops medication, does coverage change?
Not on an existing policy that already covers the condition, which continues under its terms. The question matters for a new policy: a form that classes epilepsy as chronic will keep it excluded even after remission. The IVETF reports remission in 15 to 30 percent of dogs in hospital-based populations, so this situation does occur.
Does breed affect whether epilepsy is covered?
It affects the odds and the timing, not usually the coverage itself, on the forms read for this guide. Healthy Paws lists epilepsy among hereditary conditions that are eligible when signs first appear after enrollment. A form with a congenital and inherited exclusion needs a closer read: the AKC sample does not name epilepsy in its printed list, so ask how it classifies idiopathic epilepsy.
Sources and verification
- Berendt M et al., IVETF consensus report on epilepsy definition, classification and terminology in companion animals, BMC Veterinary Research 11:182 (2015): Definitions of epilepsy, reactive seizure, structural and idiopathic epilepsy, cluster seizures and status epilepticus; prevalence estimated at 0.6 to 0.75 percent; Labrador Retriever breed study at 3.1 percent. Full text read via Europe PMC (PMC4552272). Checked October 30, 2026.
- De Risio L et al., IVETF consensus proposal: diagnostic approach to epilepsy in dogs, BMC Veterinary Research 11:148 (2015): Tier I and Tier II criteria, onset between 6 months and 6 years, MRI and CSF recommendations. Full text read via Europe PMC (PMC4552251). Checked October 30, 2026.
- Bhatti SFM et al., IVETF consensus proposal: medical treatment of canine epilepsy in Europe, BMC Veterinary Research 11:176 (2015): Treatment generally lifelong; remission 15 to 30 percent in hospital-based populations; phenobarbital monitoring schedule; newer human drugs used as add-on treatment. Full text read via Europe PMC (PMC4552371). Checked October 30, 2026.
- Kearsley-Fleet L et al., Prevalence and risk factors for canine epilepsy of unknown origin in the UK, Veterinary Record 172 (2013): Abstract read via Europe PMC: 92 VetCompass clinics, 539 cases, prevalence 0.62 percent; males over 1.5 times as likely; Border Terrier OR 2.70, German Shepherd OR 1.90. Checked October 30, 2026.
- Erlen A et al., Seizure occurrence in dogs under primary veterinary care in the UK: prevalence and risk factors, Journal of Veterinary Internal Medicine 32 (2018): Abstract read via Europe PMC (PMC6189390): 455,553 dogs; one-year prevalence of at least one seizure 0.82 percent; Pug OR 3.41 against Labrador Retriever; age 3 to 6 OR 2.13. Checked October 30, 2026.
- Hülsmeyer VI et al., International Veterinary Epilepsy Task Force's current understanding of idiopathic epilepsy of genetic or suspected genetic origin in purebred dogs, BMC Veterinary Research 11:175 (2015): IVETF breed review, as carried on the breed profiles: Border Collie median first seizure 2.4 years, 18 percent at or under 1 year, 94 percent with clusters; Australian Shepherd median onset 2.5 years, first event a cluster or status epilepticus in 28 percent; Vizsla (Patterson et al. 2003) median onset 3 years, 79 percent focal. Checked October 22, 2026.
- O'Neill DG et al., Beagles kept as companion animals in the UK: demography, disorders and mortality, Companion Animal Health and Genetics (2025): VetCompass records from 2019, 3,729 Beagles: seizure disorder 2.04 percent (76 dogs), median age 7.45 years among affected dogs. As carried on the Beagle profile. Checked October 22, 2026.
- Wong K, Williamson P, Taylor RM, Demography and Causes of Mortality of Pugs Under Primary Veterinary Care in Australia, Veterinary Sciences (2025): Australian VetCompass data, abstract: 691 Pug deaths; seizures 6.7 percent of recorded causes of death. As carried on the Pug profile. Checked October 22, 2026.
- US Food and Drug Administration, Conditional Approval of Potassium Bromide for Dogs: An Innovative Approach (2021, historical): Historical statement, content current as of February 12, 2021: at that date neither phenobarbital nor potassium bromide was fully approved to control seizures in people or animals; KBroVet-CA1 conditional approval January 2021; full approval required within five years; idiopathic epilepsy described as affecting about 5 percent of dogs. Superseded for potassium bromide by the January 21, 2026 full approval listed next. Checked October 30, 2026.
- US Food and Drug Administration, FDA Grants Full Approval of a Drug to Control Seizures in Dogs with Idiopathic Epilepsy (CVM Update): January 21, 2026: full approval of KBroVet (potassium bromide chewable tablets, NADA 141-615) for the control of seizures in dogs with idiopathic epilepsy, after conditional approval in January 2021 and four annual renewals; idiopathic epilepsy described as affecting approximately 5 percent of dogs. Checked October 30, 2026.
- US Food and Drug Administration, FDA Conditionally Approves Phenobarbital Tablets to Control Seizures in Dogs with Idiopathic Epilepsy: September 6, 2023: Fidoquel-CA1 conditional approval, the second drug approved for seizure control in dogs with idiopathic epilepsy; unapproved human-market phenobarbital tablets historically used; one-year conditional approval with up to four renewals. No full-approval notice for Fidoquel-CA1 was found in the FDA pages read October 30, 2026. Checked October 30, 2026.
- University of Missouri Veterinary Health Center, Neurology and Neurosurgery FAQs: Initial neurologic exam and evaluation $195; MRI or CT "would be between $3,000-$4,000" including imaging, anesthesia, pre-anesthetic blood work and radiographs as needed, and spinal fluid tap and testing; prices evaluated annually. Checked October 30, 2026.
- Spot Arizona accident and illness sample policy (PET-P-20000-1024): FDA-approved prescription medication benefit; chronic condition, illness, Occur and pre-existing definitions; cured condition route not applying to chronic conditions. Checked October 30, 2026.
- AKC Pet Insurance North Carolina sample policy (form IAIC PPI AI POL 007 NC 0421): Prescription medication definition; incident definition counting recurring or chronic incidents as one; per-incident limits not resetting; pre-existing conditions eligible after 365 days of continuous coverage; exam fee exclusion unless ExamPlus; congenital and inherited exclusion list. Checked October 30, 2026.
- Embrace, prescription drug coverage page and coverage FAQ: Take-home prescriptions with every policy for FDA-approved and Homeopathic Pharmacopoeia-included drugs for covered conditions; FAQ (embracepetinsurance.com/coverage/faq): curable conditions eligible after 12 months symptom free, diabetes and allergies as incurable examples, exam fees an optional add-on. Checked October 30, 2026.
- Healthy Paws FAQ and Lemonade pre-existing conditions explainer: Healthy Paws: epilepsy among hereditary condition examples; seizures among conditions not considered cured; exam fees not covered. Lemonade (lemonade.com/pet/explained/pet-insurance-pre-existing-conditions/, last updated October 13, 2026): chronic conditions cannot be cured. Checked October 30, 2026.
Clinical descriptions are summarised from the IVETF consensus papers and VetCompass studies for insurance education only; they do not describe any individual dog, and whether an episode is a seizure is for a veterinarian to say. The five-year example uses round inputs except the University of Missouri figures, and its policy shapes stand for no insurer's product. Sample forms are single-state examples, and your own policy form and declarations page govern any claim. Scope: US policies in US dollars.